Chemed Corporation $CHE Shares Sold by Quantinno Capital Management LP

Quantinno Capital Management LP reduced its holdings in shares of Chemed Corporation (NYSE:CHE) by 55.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,603 shares of the company’s stock after selling 8,251 shares during the quarter. Quantinno Capital Management LP’s holdings in Chemed were worth $2,494,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Monetary Solutions Ltd acquired a new stake in Chemed in the fourth quarter valued at $25,000. Los Angeles Capital Management LLC acquired a new position in Chemed during the 4th quarter worth $26,000. BOK Financial Private Wealth Inc. acquired a new position in Chemed during the 4th quarter worth $27,000. Global Retirement Partners LLC increased its position in shares of Chemed by 200.0% in the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after purchasing an additional 58 shares during the last quarter. Finally, Geneos Wealth Management Inc. increased its position in shares of Chemed by 330.4% in the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Trading Down 0.1%

Chemed stock opened at $552.28 on Monday. The firm’s 50-day moving average is $477.97 and its 200-day moving average is $439.75. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $553.00. The company has a market cap of $7.22 billion, a P/E ratio of 27.74, a PEG ratio of 2.09 and a beta of 0.51.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The business had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, equities analysts expect that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. This is a boost from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. Chemed’s dividend payout ratio is currently 12.05%.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CHE. Royal Bank Of Canada increased their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. Bank of America reissued a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Oppenheimer upped their price objective on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Wall Street Zen upgraded Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $530.75.

Insider Transactions at Chemed

In related news, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares in the company, valued at $2,047,876.74. The trade was a 22.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Patrick P. Grace sold 190 shares of the company’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total value of $101,080.00. Following the transaction, the director owned 3,533 shares of the company’s stock, valued at approximately $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 3,537 shares of company stock worth $1,782,654. 3.33% of the stock is currently owned by company insiders.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.